Respiratory Syncytial Virus Predisposes Mice to Augmented Allergic Airway Responses Via IL-13-Mediated Mechanisms1

The development of severe childhood asthma may be influenced by several factors including environmental and infectious stimuli. The causal relationship between infectious viral responses, such as respiratory syncytial virus (RSV), and severe asthma during early childhood is unclear. In these studies, the ability for an initial RSV infection to exacerbate and promote a more severe asthmatic-type response was investigated by combining established murine models of disease. We examined the ability of RSV to induce exacerbation of allergic disease over a relatively long period, leading to development of severe airway responses including airway inflammation and hyperreactivity. The preferential production of IL-13 during a primary RSV infection appears to play a critical role for the exacerbation of cockroach allergen-induced disease. The depletion of IL-13 during RSV infections inhibited the exacerbation and acceleration of severe allergen-induced airway hyperreactivity. This was indicated by decreases in airway hyperreactivity and changes in lung chemokine production. These data suggest that the airway responses during asthma can be greatly affected by a previous RSV infection, even when infection occurs before allergen sensitization. Overall, infection of the airways with RSV can induce an IL-13-dependent change in airway function and promotes an environment that contributes to the development of severe allergic asthmatic responses.

[1]  R. Parker,et al.  Respiratory syncytial virus infection does not increase allergen‐induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice , 2001, Journal of medical virology.

[2]  L. Krilov,et al.  Influenza and respiratory syncytial virus. Update on infection, management, and prevention. , 2000, Pediatric clinics of North America.

[3]  R. Davis,et al.  Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.

[4]  R. Strieter,et al.  Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation1 , 2000, The Journal of Immunology.

[5]  E. Arranz,et al.  Decreased interleukin‐12 levels in umbilical cord blood in children who developed acute bronchiolitis , 1999, Pediatric pulmonology.

[6]  R. Strieter,et al.  Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. , 1999, Journal of immunology.

[7]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[8]  T. Nishi,et al.  A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. , 1999, Journal of immunology.

[9]  J. McBride Pulmonary function changes in children after respiratory syncytial virus infection in infancy. , 1999, The Journal of pediatrics.

[10]  G. Yu,et al.  Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.

[11]  S. Long Syndrome of Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA)--what it isn't. What is it? , 1999, The Journal of pediatrics.

[12]  J. Wildhaber,et al.  Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. , 1999, The Journal of pediatrics.

[13]  D. Taub,et al.  Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. , 1999, Journal of immunology.

[14]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[15]  E. Gelfand,et al.  IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. , 1999, Journal of immunology.

[16]  T. Mosmann,et al.  Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. , 1999, Journal of immunology.

[17]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[18]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[19]  R. Strieter,et al.  Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. , 1998, Journal of immunology.

[20]  M. Rihanek,et al.  STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. , 1998, Journal of immunology.

[21]  C. Jaén Cockroach allergen and asthma. , 1997, The New England journal of medicine.

[22]  H. Teichtahl,et al.  The Incidence of Respiratory Tract Infection in Adults Requiring Hospitalization for Asthma , 1997, Chest.

[23]  E. Gelfand,et al.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. , 1997, The Journal of clinical investigation.

[24]  E. Bröcker,et al.  Interleukin‐13 selectively induces monocyte chemoattractant protein‐1 synthesis and secretion by human endothelial cells. Involvement of IL‐4Rα and Stat6 phosphorylation , 1997, Immunology.

[25]  R. Bravo,et al.  Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. , 1997, Journal of immunology.

[26]  S. Holgate,et al.  Mechanisms of virus induced exacerbations of asthma. , 1997, Thorax.

[27]  G. Canny,et al.  Hospitalization patterns in severe acute asthma in children , 1997, Pediatric pulmonology.

[28]  M. Gershwin,et al.  Why is asthma becoming more of a problem? , 1997, Current opinion in pulmonary medicine.

[29]  R. Bjerknes,et al.  Serum eosinophil cationic protein and interleukin‐5 in children with bronchial asthma and acute bronchiolitis , 1996, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[30]  R. Bascom Environmental factors and respiratory hyper sensitivity: the Americas , 1996 .

[31]  J. Roberts Cockroaches linked with asthma , 1996, BMJ.

[32]  A. Mielck,et al.  Severity of childhood asthma by socioeconomic status. , 1996, International journal of epidemiology.

[33]  W. König,et al.  Respiratory syncytial virus G‐protein modulates cytokine release from human peripheral blood mononuclear cells , 1996, Journal of leukocyte biology.

[34]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[35]  R. Welliver RSV and chronic asthma , 1995, The Lancet.

[36]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[37]  C. Sanderson,et al.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. , 1989, Blood.

[38]  T. Suda,et al.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors , 1988, The Journal of experimental medicine.

[39]  Ennis,et al.  THE ROLE OF COCKROACH ALLERGY AND EXPOSURE TO COCKROACH ALLERGEN IN CAUSING MORBIDITY AMONG INNER-CITY CHILDREN WITH ASTHMA , 2000 .

[40]  H. Eigen The RSV-asthma link: the emerging story. Introduction. , 1999, The Journal of pediatrics.

[41]  F. Martinez Definition of pediatric asthma and associated risk factors , 1997, Pediatric pulmonology. Supplement.

[42]  W. Busse,et al.  The role of respiratory viruses in asthma. , 1997, Ciba Foundation symposium.

[43]  R. Bascom Environmental factors and respiratory hypersensitivity: the Americas. , 1996, Toxicology letters.

[44]  P. Sly,et al.  Childhood asthma following hospitalization with acute viral bronchiolitis in infancy , 1989, Pediatric pulmonology.

[45]  I. Antépara,et al.  The viral factor in the etiology of acute asthma attacks in children. , 1981, Allergologia et immunopathologia.